Certara Inc (NAS:CERT)
$ 13.29 0.29 (2.23%) Market Cap: 2.14 Bil Enterprise Value: 2.22 Bil PE Ratio: 0 PB Ratio: 2.05 GF Score: 83/100

Certara Inc at Jefferies London Healthcare Conference Transcript

Nov 15, 2022 / 04:25PM GMT
Release Date Price: $15.58 (+6.42%)
David Howard Windley
Jefferies LLC, Research Division - MD & Equity Analyst

Thank you for your attendance at our Jefferies London Healthcare Conference. Appreciate your interest here in our health care company guests. I'm Dave Windley with Jefferies Healthcare Equity Research in States and cover drug development supply chain related, I'll call it, the CROs, CDMOs. Certara happens to be a software biosimulation focused player, but selling exclusively in the biopharma R&D and regulatory services area. So here to represent Certara is the company's CEO, William Feehery. Bill, thanks for being here. Really appreciate you being here to talk about Certara.

Questions & Answers

David Howard Windley
Jefferies LLC, Research Division - MD & Equity Analyst

So let me start you off with just talking about the sales dynamics of biosimulation. I think when the company came public in 2020 -- late 2020, was in the throes of the pandemic. We were bringing a COVID vaccine through the pipeline very, very quickly. And people viewed -- it was kind of a new

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot